Crescent Biopharma (CBIO) Share-based Compensation (2013 - 2026)
Crescent Biopharma (CBIO) posted Share-based Compensation of $3.97 million for Q2 2026, down 25.7% from $5.34 million a year earlier and down 3.6% from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Share-based Compensation (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Crescent Biopharma was $14.81 million, up 67.5% year-over-year; for FY2025, it came in at $13.3 million, up 183.1% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 14.0% (FY2020 to FY2025).
- In prior years, Crescent Biopharma's Share-based Compensation was $4.7 million in FY2024 (+33.3%), $3.52 million in FY2023 (-8.6%), $3.86 million in FY2022 (-36.6%) and $6.09 million in FY2021 (-11.8%).
- Quarterly Share-based Compensation has run from a low of $858,088 in Q2 2023 to a high of $5.34 million in Q2 2025 over five years.
- On a year-over-year basis, Share-based Compensation increased in seven of the last eight quarters, with growth averaging 125.0%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q2 2025, with growth of 342.3%; the weakest was Q3 2022, with a decline of 42.5%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $4.11 million (Q1 2026), $4.75 million (Q4 2025) and $1.99 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Crescent Biopharma | 418.60 Mn | -288.70 Mn | - | 3.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.97 Mn |
| Mar 31, 2026 | 4.11 Mn |
| Dec 31, 2025 | 4.75 Mn |
| Sep 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 5.34 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | 908,371.00 |
| Sep 30, 2023 | 887,837.00 |
| Jun 30, 2023 | 858,088.00 |
| Mar 31, 2023 | 870,180.00 |
| Dec 31, 2022 | 899,201.00 |
| Sep 30, 2022 | 913,979.00 |
| Jun 30, 2022 | 963,758.00 |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 1.59 Mn |
API Access
Crescent Biopharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();